David Diamond's most recent trade in RenovoRx Inc was a trade of 25,099 Stock Option (right to buy) done . Disclosure was reported to the exchange on Oct. 1, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
RenovoRx Inc | David Diamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2022 | 25,099 | 25,099 | - | - | Stock Option (right to buy) | |
RenovoRx Inc | David Diamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 9,165 | 9,165 | - | - | Stock Option (right to buy) | |
RenovoRx Inc | David Diamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 4,582 | 4,582 | - | - | Stock Option (right to buy) | |
RenovoRx Inc | David Diamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 22,307 | 22,307 | - | - | Stock Option (right to buy) | |
RenovoRx Inc | David Diamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 11,154 | 33,461 | - | - | Stock Option (right to buy) |